Homepage
Open in app
Sign in
Get started
ZS
Impact where it matters.
Follow
Oncology vertical goes to PMSA
Oncology vertical goes to PMSA
Deepika Sinha and Jeevan Elanchelvan, leaders in the oncology vertical at ZS, attended the PMSA Conference. Read their key takeaways.
Jeevarasan Elanchelvan
Jun 2
CMS sales and marketing rules and implications for AEP 2025: Navigating changes in how agents are…
CMS sales and marketing rules and implications for AEP 2025: Navigating changes in how agents are…
The Centers for Medicare & Medicaid Services (CMS) has recently adjusted several rules impacting agent and broker compensation.
Daniel Galajda
May 29
Designing for the ACNU consumer experience
Designing for the ACNU consumer experience
Learn about the importance of the consumer experience (CX) in ACNU.
Dan Frey
May 24
The business of beauty: The evolving med spa landscape and opportunities for manufacturers
The business of beauty: The evolving med spa landscape and opportunities for manufacturers
The med spa revolution is well underway, and those manufacturers who can rise to the occasion will be poised to thrive.
Yasasvi Popuri
May 24
Pharma DTC marketing 2.0 is digital health
Pharma DTC marketing 2.0 is digital health
Pharmaceutical companies must embrace digital health solutions as a powerful wraparound to their marketing efforts.
Vijesh Unnikrishnan
May 24
From data to decisions: Leveraging Generative AI and data products
From data to decisions: Leveraging Generative AI and data products
Abhinav Batra and I were invited to speak at the Pharma SOS Conference. Learn more about our favorite topics, data products and Gen AI.
Willem Koenders
May 15
Break down how your customers make decisions with strategies that enable the elusive goal: N=1…
Break down how your customers make decisions with strategies that enable the elusive goal: N=1…
ZS is offering a new approach to achieve every marketer’s dream — nano-segmentation to support omnichannel planning and execution.
Adnan Patel
May 15
AI partnerships in medtech: A cause for cautious optimism
AI partnerships in medtech: A cause for cautious optimism
Learn about the promise and challenges about AI partnerships in medtech.
Bhargav Mantha
Apr 25
Pushing the generics button on the biosimilars contracting
Pushing the generics button on the biosimilars contracting
Unpacking alliances between biosimilar manufacturers and payers: A deep dive by ZS’s Biosimilars CoE
Prateek Yadav
Apr 13
Early-stage funding opportunities in Singapore: An interview with Guy Heathers Albatroz…
Early-stage funding opportunities in Singapore: An interview with Guy Heathers Albatroz…
The first step is the hardest: In the dynamic world of biotechnology, the journey begins with securing early-stage funding.
Mei Chee Lim
Apr 12
Advancing clear vision: Collaborating to address the escalating myopia epidemic
Advancing clear vision: Collaborating to address the escalating myopia epidemic
Our journey to treat myopia and prevent blindness must begin now.
Ashley John
Apr 9
Navigating uncertainty: The role of AI in addressing commercial challenges during a new drug launch
Navigating uncertainty: The role of AI in addressing commercial challenges during a new drug launch
In the world of pharmaceuticals, the launch phase is a pivotal stage where anticipation intertwines with uncertainty.
Debajyoti Das
Apr 8
The future of clinical development: Opportunities for disruption
The future of clinical development: Opportunities for disruption
With an increasing focus on improving efficiency and acceleration of clinical trials, we review opportunities for disruption.
Sowmyanarayan Srinivasan
Apr 8
ZS APAC Gen AI Summit: Exploring the power of Gen AI
ZS APAC Gen AI Summit: Exploring the power of Gen AI
Learn about how AI is reshaping industries and revolutionizing the way we live and work.
Manvi Kapoor
Apr 5
About ZS Associates
Latest Stories
Archive
About Medium
Terms
Privacy
Teams